文献速递乳腺癌放疗放疗物理与技术

基于生物效应建模的局部晚期左侧乳腺癌逆向放疗计划

Inverse radiotherapy planning based on bioeffect modelling for locally advanced left-sided breast cancer.
PubMed 文献 · Radiother Oncol · 2019-04-03

纳入39例左侧乳腺癌保乳术后接受全乳及区域适形放疗的患者,用院内粒子群优化引擎从预设射野中选野并优化监视器单位,以最小化乳腺癌复发及放射性缺血性心脏病、第二肺癌、第二乳腺癌所致死亡的总风险。个体化计划较临床计划的中位总风险降低幅度有限,提示当前临床计划已接近最优。

要点

  • 临床计划中全部患者的正常组织并发症概率即缺血性心脏病、第二肺癌和第二乳腺癌风险之和<3.7%,乳腺癌复发风险<6.1%。
  • 个体化粒子群优化计划较临床计划的中位总死亡风险降低0.4%(范围0.06-2.0%),中位复发风险降低0.5%(范围0.11-2.2%)(无/有风险因素)。
  • 基于生物效应概率模型的逆向计划优化可按患者特异性风险因素实现个体化,但多数患者模型获益有限。

核心结论

  • 基于生物效应概率模型的逆向放疗计划优化可按患者特异性风险因素实现个体化。
  • 与临床计划相比,模型获益在多数患者中有限,表明当前临床计划已接近最优。
  • 以发病率终点而非死亡率终点可能获得更大获益。

研究设计与样本

  • 纳入39例左侧乳腺癌保乳术后接受全乳及区域适形放疗的患者。
  • 采用院内粒子群优化(PSO)引擎从大量预设射野中选择射野并优化监视器单位。
  • 风险模型基于已发表的多机构数据开发,纳入患者年龄、吸烟状态和心脏风险。

主要发现

  • 临床计划的正常组织并发症概率即缺血性心脏病、第二肺癌和第二乳腺癌风险之和<3.7%。
  • 临床计划的乳腺癌复发风险<6.1%(全部患者)。
  • 个体化PSO计划较临床计划的中位总死亡风险降低0.4%(范围0.06-2.0%),中位复发风险降低0.5%(范围0.11-2.2%)(无/有风险因素)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Treatment planning of radiotherapy (RT) for left-sided breast cancer is a challenging case. Several competing concerns are incorporated at present through protocol-defined dose-volume constraints, e.g. cardiac exposure and target coverage. Such constraints are limited by neglecting patient-specific risk factors (RFs). We propose an alternative RT planning method based solely on bioeffect models to minimize the estimated risks of breast cancer recurrence (BCR) and radiation-induced mortality endpoints considering patient-specific factors. METHODS AND MATERIALS: Thirty-nine patients with left-sided breast cancer treated with comprehensive post-lumpectomy loco-regional conformal RT were included. An in-house particle swarm optimization (PSO) engine was used to choose fields from a large set of predefined fields and optimize monitor units to minimize the total risk of BCR and mortality caused by radiation-induced ischaemic heart disease (IHD), secondary lung cancer (SLC) and secondary breast cancer (SBC). Risk models included patient age, smoking status and cardiac risk and were developed using published multi-institutional data. RESULTS: For the clinical plans the normal tissue complication probability, i.e. summed risk of IHD, SLC and SBC, was <3.7% and the risk of BCR was <6.1% for all patients. Median total decrease in mortality or recurrence achieved with individualized PSO plans was 0.4% (range, 0.06-2.0%)/0.5% (range, 0.11-2.2%) without/with risk factors. CONCLUSIONS: Inverse RT plan optimization using bioeffect probability models allows individualization according to patient-specific risk factors. The modelled benefit when compared to clinical plans is, however, modest in most patients, demonstrating that current clinical plans are close to optimal. Larger gains may be achievable with morbidity endpoints rather than mortality.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Stick LB, Vogelius IR, Modiri A, et al. Inverse radiotherapy planning based on bioeffect modelling for locally advanced left-sided breast cancer. Radiother Oncol. 2019. PMID: 31015135. doi:10.1016/j.radonc.2019.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。